(Reuters) - Valeant Pharmaceuticals Inc said on Wednesday it began an exchange offer for Botox maker Allergan Inc, taking its hostile $50.8 billion bid directly to shareholders. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/pcO58ySF3_c/story01.htm
Read More
No comments:
Post a Comment